Testosterone Enanthate

庚酸睾酮

Report date: 2025/03/28 15:48:48
NME

Base Information

Drug NameTestosterone Enanthate
Drug Alias NameTestosterone Heptanoate睾酮庚酸酯Testoviron depotDelatestrylQuickShot Testosterone +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsAndrogen deficiencyMenopausal symptomsWounds and Injuries +[22] 
Global Approved IndicationsHypogonadismPrimary MyelofibrosisAnemia, Aplastic +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1953/12/24
Country/TerritoryCanadaUnited StatesAustralia +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteAdvanz Pharma Holdco LtdUniversity Of Florida +[5] 
Inactive CompaniesThe Brigham and Women's HospitalGlaxosmithkline PlcEndo Pharmaceuticals Inc
Active IndicationsAndrogen deficiencyMobility LimitationHypogonadism +[16] 
Inactive IndicationsMenopausal symptomsWounds and InjuriesCachexia +[6] 

Other Information

ATC CodeG03BA03
Related LinksWikipediaDrugBankKEGG